इंटरनेशनल जर्नल ऑफ़ स्कूल एंड कॉग्निटिव साइकोलॉजी
खुला एक्सेस

अमूर्त

How Biomarkers Associated with Clinical trial designs

Gavin Coney

Precision medicine has proven to achieve success in treating cancers because it is ready-made to a patient’s specific needs. due to this tradition approach to treatment, however, planning a clinical test for precision medicine is markedly tougher than more conventional treatments. Unlike traditional drugs and biologics, clinical test designs for precision medicine must consider patients’ variability in genes. As a result, biomarker use in precision medicine has been critical for outlining patient segments, selecting trial locations and measuring trial success